Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report

Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report

Abstract Background Pseudomyogenic hemangioendothelioma (PMHE) is a rare endothelial neoplasm that involves the bones in only 14% of all cases. The optimal treatment strategy has not been established. We herein report a case of primary PMHE in which denosumab treatment showed activity in both imagin...

Full description

Bibliographic Details
Main Authors: Shinya Otani, Robert Nakayama, Tetsuya Sekita, Toru Hirozane, Naofumi Asano, Kazumasa Nishimoto, Aya Sasaki, Hajime Okita, Hideo Morioka, Masaya Nakamura, Morio Matsumoto
Format: Article
Language:English
Published: BMC 2019-09-01
Series:BMC Cancer
Subjects:
Pseudomyogenic hemangioendothelioma
Denosumab
Osteoclast-like giant cells
FOSB
Online Access:http://link.springer.com/article/10.1186/s12885-019-6072-8

Internet

http://link.springer.com/article/10.1186/s12885-019-6072-8

Similar Items